Skip to main content

ADVERTISEMENT

Philip Cyr, MPH

Pharma Insights
04/17/2018
Philip Cyr, MPH
Larry Blandford, PharmD—Column Editor
Various forms of decision health analytic modeling have been used for the last 3 decades to assess potential health economic impact of new therapies. As initial gene and cellular therapies come to market, debate is...
Various forms of decision health analytic modeling have been used for the last 3 decades to assess potential health economic impact of new therapies. As initial gene and cellular therapies come to market, debate is...
...
04/17/2018
Journal of Clinical Pathways